logo
Most Americans Are Stressed About Grocery Costs — As Food Prices Climb

Most Americans Are Stressed About Grocery Costs — As Food Prices Climb

Forbes2 hours ago
Almost 90% of American adults say they're stressed about the cost of groceries, a new poll out Monday shows, as the price of food rises and items like poultry, ground beef and eggs see the biggest cost jumps.
A customer shops at an H-E-B grocery store on February 12, 2025 in Austin, Texas. Getty Images
More than half of Americans (53%) see grocery prices as a major source of stress and another 33% see it as a minor source of stress, according to a new poll from the Associated Press-NORC Center for Public Affairs Research.
More people were concerned about grocery prices than any other financial concern brought up in the poll, but more than half of respondents also said they were at least somewhat stressed about their salaries, the cost of housing, the amount of money they have saved, their credit card debt and the cost of health care.
The Consumer Price Index shows the price of food has risen 3% in the last 12 months—groceries have risen 2.4% while dining out is 3.8% costlier than it was 12 months ago.
From June 2024 to June 2025, groceries got more expensive in every category tracked by the Bureau of Labor Statistics: meats, poultry, fish and eggs rose in price by 5.6% (egg prices alone rose 27.3%); nonalcoholic beverages are 4.4% more expensive; fruits and vegetables rose in price by 0.7%; and both cereals and bakery products and the index for dairy products rose 0.9%.
At 3%, the cost of food is rising faster than the overall inflation rate as measured by the Consumer Price Index, at 2.7%.
After groceries, the price of housing had the highest number of people reporting it as a major stressor in Monday's poll (47%), followed by the amount of money saved (43%), salary (43%) and the cost of health care (42%).
Get Forbes Breaking News Text Alerts: We're launching text message alerts so you'll always know the biggest stories shaping the day's headlines. Text 'Alerts' to (201) 335-0739 or sign up here : joinsubtext.com/forbes.
81 cents. That's how much the price of chicken breast increased, per pound, from July 2024 to July 2025, according to NBC News, making it the largest price hike among the six staple items tracked by the outlet. The cost of ground beef increased 67 cents per pound, while eggs grew 64 cents more expensive per dozen.
While food prices are up despite President Donald Trump's campaign promise to "immediately bring prices down,' 3% is nowhere near the double-digit jumps earlier in the decade. Food inflation was 10.4% in 2022 and 6.3% in 2021. This year is so far slightly above, but largely in line, with price increases in 2023 (2.7%) and 2024 (2.5%). Are Tariffs Going To Make Groceries More Expensive?
Probably. The Budget Lab at Yale estimates that tariff price increases will raise food costs by about another 3%. Fresh produce could initially jump in price by almost 7% before stabilizing long-term at 3.6% higher, and processed rice is expected to rise in price by 10.2% in the long term. Other items expected to cost more include beverages, cereal and grains, sugar, meat and dairy products, Yale said. Grocery products imported from other countries, like bananas, beer, wine and cheese, will face additional tariffs. In 2024, the U.S. imported about $221 billion in food products, 62% of which came from five countries: Mexico, Canada, the EU, Brazil and China, according to the Tax Foundation. Trump has agreed to pause higher tariffs on Mexico for 90 days, and has agreed to a 15% tariff on goods from the EU. The White House said Canada will face a 35% tariff rate—up from an earlier 25%—for goods not covered under the United States-Mexico-Canada Agreement (USMCA). Trump has threatened a 50% tariff on Brazil due to the ongoing criminal prosecution of his ally and the country's former president, Jair Bolsonaro, and the average tariff on Chinese exports is currently 55%. Further Reading Forbes Advisor Food Prices Rise Again: How To Save On Groceries And Dining Out In 2025 Forbes Rising Prices Are Changing The Way Americans Eat—Here's What's Next By Stephanie Gravalese Forbes Trump Announces New Global Tariff Rates—As He Pushes Back Start Date Again By Siladitya Ray
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop
Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop

Yahoo

time12 minutes ago

  • Yahoo

Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop

Key Takeaways Novo Nordisk's U.S.-listed shares were slightly higher in recent trading after shedding a third of their value last week, when the company cut its full-year outlook and named a new CEO. The shares had resumed their steep downtrend last week on above-average volume, indicating selling conviction from larger market participants. Investors should watch major support levels on Novo Nordisk's chart around $36 and $29, while also monitoring key overhead areas near $60 and $ Nordisk's (NVO) U.S.-listed shares were up about 2% in recent trading after shedding about a third of their value last week, when the company cut its full-year outlook and named a new CEO, leading Wall Street analysts to downgrade the stock. Since hitting a record high in June last year, Novo Nordisk shares have lost roughly two-thirds of their value, pressured by increasing competition from rival Eli Lilly's (LLY) weight-loss drugs and challenges during trials of the company's next-generation obesity drugs. Below, we take a closer look at Novo Nordisk's weekly chart and use technical analysis to identify major price levels that investors will likely be watching after last week's dramatic sell-off. An Extended Downtrend With last week's drop, Novo Nordisk shares resumed their steep downtrend on above-average trading volume, indicating selling conviction from larger market participants. The sell-off coincided with the relative strength index (RSI) falling to its lowest levels since early May, signaling weakening price momentum, though the indicator neared its oversold threshold, increasing the chances for short-term bounces. It's also worth noting that the 50-week moving average continues to converge toward the 200-week MA, potentially setting the stage for an ominous death cross, a bearish pattern that forecasts lower prices. Let's identify two major support levels on Novo Nordisk's chart worth watching if selling resumes this week and also point out several key overhead areas to monitor during potential recovery efforts. Major Support Levels Worth Watching The first major lower level to watch sits around $36. This area would likely provide support near the upper range of a consolidation period that formed on the chart between October 2020 and April 2021. A more significant move lower could see the shares test lower support at the $29 level. Investors may look for buying opportunities in this area near a horizontal line that connects a range of corresponding price action on the chart between January 2018 and April 2020. Key Overhead Areas to Monitor An initial recovery effort could see the shares climb to overhead resistance around $60. The price may encounter selling pressure in this area near the prominent April trough and April 2022 peak. A more bullish upswing opens the door for a rally toward $78. Investors who have bought Novo Nordisk shares at lower levels may decide to lock in profits in this location near the June peak, which closely aligns with the completion of a pullback in July 2023. The comments, opinions, and analyses expressed on Investopedia are for informational purposes only. Read our warranty and liability disclaimer for more info. As of the date this article was written, the author does not own any of the above securities. Read the original article on Investopedia Sign in to access your portfolio

NCAA Tournament fields to remain at 68 teams in 2026, but future growth is possible
NCAA Tournament fields to remain at 68 teams in 2026, but future growth is possible

Yahoo

time12 minutes ago

  • Yahoo

NCAA Tournament fields to remain at 68 teams in 2026, but future growth is possible

The NCAA men's and women's basketball tournaments will not expand beyond 68 teams in 2026, but future growth remains on the radar. 'Expanding the tournament fields is no longer being contemplated for the 2026 men's and women's basketball championships," Dan Gavitt, NCAA senior vice president of basketball, said in a statement on Monday. "However, the committees will continue conversations on whether to recommend expanding to 72 or 76 teams in advance of the 2027 championships.' NCAA President Charlie Baker has said adding teams could add value to the tournament, and he said the NCAA already has had 'good conversations' with TV partners CBS and Warner Bros., whose deal runs through 2032 at the cost of around $1.1 billion a year. ___ AP college basketball: and

RGTI: Rigetti Shares Jump after Needham hikes target on U.S. quantum momentum
RGTI: Rigetti Shares Jump after Needham hikes target on U.S. quantum momentum

Yahoo

time12 minutes ago

  • Yahoo

RGTI: Rigetti Shares Jump after Needham hikes target on U.S. quantum momentum

Aug 4 - Rigetti Computing (NASDAQ:RGTI) jumped more than 5% on Monday shortly after Needham raised its price target by $3, signaling fresh momentum in quantum computing. Warning! GuruFocus has detected 3 Warning Signs with RGTI. Analyst Quinn Bolton sees growing buzz around federal programs like DARPA's Quantum Benchmark Initiative (QBI) and the proposed Department of Energy Quantum Leadership Act. He believes those efforts could unlock new research funding and commercial opportunities. Rigetti leads a pack of startups racing to prove quantum machines can outperform classical systems. QBI aims to assess whether quantum devices deliver more value than their cost by 2033. Meanwhile, the DOE bill would allocate $2.5 billion over five years to boost quantum research. Investors weigh the promise of those programs against current realities: most quantum firms still run R&D losses and generate modest revenue. Bolton urges a cautious stance, recommending smaller, speculative positions. Yet his buy rating on Rigetti reflects confidence that government backing could pave the way for breakthroughs and higher stock gains. With Washington pulling out all the stops to keep the U.S. on the leading edge of high-tech, Rigetti advocacy demonstrates the crossroad of policy and private money. This is the place to keep an eye on future legislative actions and DARPA milestones to get new startup catalysts. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store